Skip to main content

Resources tagged with “stroke ”

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone

Apr 3, 2018

Gore Announces Positive Results from REDUCE Clinical Study for PFO Closure

Study met its primary endpoint with PFO closure in conjunction with antiplatelet therapy, reducing recurrent stroke by > 75% over antiplatelet therapy alone

May 16, 2017

Gore REDUCE Clinical Study Completes Enrollment

Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone

Feb 25, 2015